IRB-approved collaboration initiated to demonstrate clinical value of Columbia Care’s precisely formulated, pharmaceutical-quality cannabis-based medicine,   ClaraCeed™,   through rigorous scientific research with leading medical practice in significant, underserved patient population NEW YORK &

First quarter 2019 revenue increase of 45% over prior year Completion of go-public transaction provides capital to fund long-term growth prospects Expansion of US footprint with 13 lease signings in Florida, dispensary openings in Brooklyn, NY and San Diego, CA, reinforcing organic growth strategy

Columbia Care to partner with experts at Montefiore Medical Center and Albert Einstein College of Medicine for initial phase of nationwide study on medical cannabis’s impact on opioid use for pain NEW YORK--(BUSINESS WIRE)-- Columbia Care Inc. (“Columbia Care”, or the “Company”) (NEO: CCHW), a

Organic growth continues to drive revenue increases of 45% for Q1 2019 and 35% for FY 2018 on year-over-year basis Closing of go-public transaction to accelerate strategy execution and long-term growth prospects NEW YORK--(BUSINESS WIRE)-- Columbia Care Inc. (“Columbia Care”, or the “Company”)

Findings demonstrate key differences in demographics and choice of medical cannabis product between patients with cancer and without cancer NEW YORK, March 26, 2019 (GLOBE NEWSWIRE) -- Columbia Care LLC, one of the nation’s leading medical cannabis companies, today announced the peer-reviewed

One of six companies awarded fully integrated license out of 146 applicants New Jersey will be the 14 th state where Columbia Care is licensed to operate NEW YORK, Dec. 18, 2018 (GLOBE NEWSWIRE) -- Columbia Care LLC (“Columbia Care”), one of the nation’s leading medical cannabis companies, today

NEW YORK, Dec. 13, 2018 (GLOBE NEWSWIRE) -- Columbia Care LLC (“Columbia Care”), the nation’s largest and most experienced medical cannabis company, announces the opening of an additional medical cannabis dispensary in Pennsylvania. The new dispensary, located at 3025 W.

NEW YORK, Dec. 03, 2018 (GLOBE NEWSWIRE) -- Columbia Care LLC (“Columbia Care”), the nation’s leading medical cannabis company, announces the opening of an additional medical cannabis dispensary in Pennsylvania. The new dispensary, located at 765 Kidder Street in Wilkes-Barre, opened today,

Launches EU and global expansion strategy with fully integrated license issued by federal government of Malta NEW YORK, Nov. 15, 2018 (GLOBE NEWSWIRE) -- Columbia Care LLC, the leading medical cannabis company in the United States (U.S.), announced today that it received notification that its

Research to be led by neurologist Orrin Devinsky, M.D., director of NYU Langone's Comprehensive Epilepsy Center and world leader in the study of epilepsy, and Dr. Terry Hamlin, associate executive director of The Center for Discovery, renowned for complex care Study will investigate the optimal